Barrier Therapeutics Cash Flow Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Net Operating Cash Flow | (48.2) | (43.3) | (44.2) |
| Net Investing Cash Flow | 18.1 | 13.2 | 12.6 |
| Net Financing Cash Flow | 38.0 | 24.3 | 36.7 |
| Net Change in Cash | 7.8 | (5.8) | 5.0 |
| Depreciation & Amortization | 0.8 | 0.9 | 1.6 |
| Capital Expenditures | (0.2) | (0.3) | (0.4) |
| Cash Dividends Paid | -- | -- | -- |
This data is provided as per license from EDGAR Online
